** Shares of Evolent Health EVH.N down 4.7% post-market to $8.60 as healthcare tech firm looks to raise capital
** Arlington, Virginia-based EVH announces private offering of $140 mln convertible bonds (CBs) due 2031
** It plans to use $100 mln of net proceeds to repurchase a portion of its 1.50% CBs due 2025
** Co also intends to use $40 mln to repurchase its stock concurrently with pricing of the offering in privately negotiated transactions
** With ~117.5 mln shares outstanding, EVH has roughly $1.1 bln market cap, per LSEG data
** EVH shares on Mon closed down 3% at $9.02, down ~20% YTD
** Of 14 analysts covering EVH, recommendation breakdown is 13 "strong buy" or "buy" and 1 "hold"; median PT is $16 - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.